Moxifloxacin vs Pembrolizumab

## Moxifloxacin vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Moxifloxacin** and **Pembrolizumab**.

## Mechanism of Action

**Moxifloxacin**: Fourth-generation fluoroquinolone inhibiting DNA gyrase and topoisomerase IV with enhanced anaerobic activity.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Moxifloxacin — 12 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Moxifloxacin — C21H24FN3O4; Pembrolizumab — N/A.

**Molecular Weight**: Moxifloxacin — 401.4350 g/mol; Pembrolizumab — N/A.

**Type**: Moxifloxacin — Small molecule; Pembrolizumab — Antibody.